calfactant
calfactant is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including INFASURF. Available dosage form: suspension.
Drug Details
- Generic Name
- calfactant
- Brand Names
- INFASURF
- Application Number
- BLA020521
- Sponsor
- ONY Biotech Inc.
- NDC Codes
- 1
- Dosage Forms
- SUSPENSION
- Routes
- ENDOTRACHEAL
- Active Ingredients
- CALFACTANT
Indications and Usage
1 INDICATIONS AND USAGE INFASURF is indicated: to reduce the risk of respiratory distress syndrome (RDS) in preterm neonates <29 weeks of gestational age at risk for RDS. for the rescue treatment of RDS in preterm neonates ≤72 hours of age with RDS who require endotracheal intubation. INFASURF ® is a surfactant indicated: to reduce the risk of respiratory distress syndrome (RDS) in preterm neonates < 29 weeks gestational age at risk for RDS. (1) for the rescue treatment of preterm neonates ≤72 hours of age with RDS who require endotracheal intubation. (1)